Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest (PBSCH)

Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest (PBSCH) - Multicenter randomized controlled prospective trial in peripheral blood stem cell harvest

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012095

Enrollment

200

Registered

2013-10-25

Start date

2013-10-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological malignancies

Interventions

Spectra-Optia will be chosen for peripheral blood stem cell harvest Spectra-Auto will be chosen for peripheral blood stem cell harvest Spectra-Optia and Spectra-Auto will be chosen for peripheral blo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who will require autologous peripheral blood stem cell transplantation (PBSCT) or donors for allogeneic PBSCT will be eligible if they undergo PBSCH. Written informed consent is required, and enrollees should be 18 years or older.

Exclusion criteria

Exclusion criteria: Patients or donors without written informed consent will be excluded.

Design outcomes

Primary

Measure	Time frame
Numbers and efficiencies of collected CD34+ cells and mononuclear cells. Contaminated unnecessary cells Frequencies of adverse reactions.	—

Countries

Japan

Contacts

Public ContactKazuhiko Ikeda

Fukushima Medical University Department of Blood Transfusion and Transplantation Immunology

kazu-ike@fmu.ac.jp024-547-1536

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026